Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Furlan

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Multiple Sclerosis and Related Disorders|August 15, 2018
Multiple sclerosis prevalence in Salta City, ArgentinaS Mellinger, D Dias, N Flores, et al.
Spine|July 4, 2006
Interobserver and intraobserver reliability of maximum canal compromise and spinal cord compression for evaluation of acute traumatic cervical spinal cord injuryMichael G Fehlings, Julio C Furlan, Eric M Massicotte, et al.
Trials|July 14, 2017
Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Global Spine Journal|February 17, 2022
Developing Peri-Operative Rehabilitation in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 6]: An Unexplored Opportunity?Timothy F Boerger, Allison S Hyngstrom, Julio C Furlan, et al.
Trials|October 25, 2017
Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Global Spine Journal|February 17, 2022
Establishing the Socio-Economic Impact of Degenerative Cervical Myelopathy Is Fundamental to Improving Outcomes [AO Spine RECODE-DCM Research Priority Number 8]Benjamin M Davies, Richard Phillips, David Clarke, et al.
Pathology Oncology Research : POR|June 22, 2020
Predictive Value of CD8 Expression and FoxP3 Methylation in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy in a Non-endemic AreaE Muraro, E Vaccher, C Furlan, et al.
Computational and Structural Biotechnology Journal|May 6, 2022
NAToRA, a relatedness-pruning method to minimize the loss of dataset size in genetic and omics analysesThiago Peixoto Leal, Vinicius C Furlan, Mateus Henrique Gouveia, et al.
Trials|August 3, 2017
Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
BMJ Open|January 20, 2022
Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM)Alvaro Yanez Touzet, Aniqah Bhatti, Esmee Dohle, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis and Related Disorders|August 15, 2018
Multiple sclerosis prevalence in Salta City, ArgentinaS Mellinger, D Dias, N Flores, et al.
Spine|July 4, 2006
Interobserver and intraobserver reliability of maximum canal compromise and spinal cord compression for evaluation of acute traumatic cervical spinal cord injuryMichael G Fehlings, Julio C Furlan, Eric M Massicotte, et al.
Trials|July 14, 2017
Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Global Spine Journal|February 17, 2022
Developing Peri-Operative Rehabilitation in Degenerative Cervical Myelopathy [AO Spine RECODE-DCM Research Priority Number 6]: An Unexplored Opportunity?Timothy F Boerger, Allison S Hyngstrom, Julio C Furlan, et al.
Trials|October 25, 2017
Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
Global Spine Journal|February 17, 2022
Establishing the Socio-Economic Impact of Degenerative Cervical Myelopathy Is Fundamental to Improving Outcomes [AO Spine RECODE-DCM Research Priority Number 8]Benjamin M Davies, Richard Phillips, David Clarke, et al.
Pathology Oncology Research : POR|June 22, 2020
Predictive Value of CD8 Expression and FoxP3 Methylation in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy in a Non-endemic AreaE Muraro, E Vaccher, C Furlan, et al.
Computational and Structural Biotechnology Journal|May 6, 2022
NAToRA, a relatedness-pruning method to minimize the loss of dataset size in genetic and omics analysesThiago Peixoto Leal, Vinicius C Furlan, Mateus Henrique Gouveia, et al.
Trials|August 3, 2017
Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.
BMJ Open|January 20, 2022
Clinical outcome measures and their evidence base in degenerative cervical myelopathy: a systematic review to inform a core measurement set (AO Spine RECODE-DCM)Alvaro Yanez Touzet, Aniqah Bhatti, Esmee Dohle, et al.
Pageof 19